AbbVie (ABBV) is a pharmaceutical giant that was spun off from Abbott Laboratories (ABT) in 2013. This has clearly worked to the benefit of shareholders, as AbbVie stock has more than tripled since being spun off, observes Bob Ciura, income expert and editor of Sure Retirement.
For further details see:
